Genepharm S.A. neuraxpharm Arzneimittel GmbH
PolandAll drugs from this manufacturer
-
The medicinal product is used in adult patients for the treatment of mild to moderately severe Alzheimer's type dementia and for the treatment of dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 2.4 mg ATC: N06DA03
-
The medicine is used in adult patients to alleviate the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 4.8 mg ATC: N06DA03
-
The medicine is used in adult patients to relieve the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 7.2 mg ATC: N06DA03
-
The medicinal product is used in adult patients to alleviate the symptoms of mild to moderately severe Alzheimer's-type dementia and dementia associated with Parkinson's disease.
Dosage form: capsules, hard
Active substance Dosage rivastigmine hydrogen tartrate 9.6 mg ATC: N06DA03